Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Role of RAB-6 GTPase in LET-23 Epidermal Growth Factor Receptor Signaling and Trafficking in C. elegans

FY 2017-18

Summary
The human body is composed of trillions of cells that must constantly communicate with one another to generate a functional organism. Part of this intercellular communication relies on interaction between ligands, found in the space between cells, and their selective receptors, found at the cells' surface. A ligand can be seen as a key, and its receptor the lock that fits it. The ligand constitutes the message that one cell wants to send to another. Once a ligand contacts its receptor, the receptor becomes activated and triggers a cascade of events inside the cell. Ultimately, this serves to indicate to the cell how to respond to the message it received. My research project seeks to reveal the details of one of these signaling cascades, namely the one triggered by activation of the epidermal growth factor receptor (EGFR). Once activated, this receptor can signal to a cell to start growing and proliferating. Unsurprisingly, uncontrolled activation of EGFR has been associated with many cancers. If this cascade is dysregulated, a cell could start proliferating and generate a tumor. Positive and negative regulation of EGFR is thus crucial for health. My research will focus on the regulation of the signaling from EGFR, specifically on the role of a protein named Rab6, which I hypothesize promotes receptor activation. Each receptor is generated inside a cell and must be trafficked to the cell surface where it will interact with its ligand. I hypothesize that Rab6 is involved in promoting the trafficking of EGFR to the right place on the cell surface so that it can contact its ligand and be activated. If Rab6 is indeed a positive regulator of EGFR, then it could potentially be targeted in treatments for cancers and other diseases associated with EGFR over-activation.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386571
Name
Gagnon Sarah
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of RAB-6 GTPase in LET-23 Epidermal Growth Factor Receptor Signaling and Trafficking in C. elegans
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
C. Elegans; Cancer; Cell Polarity; Cellular Signaling; Cellular Trafficking; Egfr; Genetics; Rab Gtpases
Abstract
The human body is composed of trillions of cells that must constantly communicate with one another to generate a functional organism. Part of this intercellular communication relies on interaction between ligands, found in the space between cells, and their selective receptors, found at the cells' surface. A ligand can be seen as a key, and its receptor the lock that fits it. The ligand constitutes the message that one cell wants to send to another. Once a ligand contacts its receptor, the receptor becomes activated and triggers a cascade of events inside the cell. Ultimately, this serves to indicate to the cell how to respond to the message it received. My research project seeks to reveal the details of one of these signaling cascades, namely the one triggered by activation of the epidermal growth factor receptor (EGFR). Once activated, this receptor can signal to a cell to start growing and proliferating. Unsurprisingly, uncontrolled activation of EGFR has been associated with many cancers. If this cascade is dysregulated, a cell could start proliferating and generate a tumor. Positive and negative regulation of EGFR is thus crucial for health. My research will focus on the regulation of the signaling from EGFR, specifically on the role of a protein named Rab6, which I hypothesize promotes receptor activation. Each receptor is generated inside a cell and must be trafficked to the cell surface where it will interact with its ligand. I hypothesize that Rab6 is involved in promoting the trafficking of EGFR to the right place on the cell surface so that it can contact its ligand and be activated. If Rab6 is indeed a positive regulator of EGFR, then it could potentially be targeted in treatments for cancers and other diseases associated with EGFR over-activation.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gagnon, Sarah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~